US FDA approves new Alzheimer's drug Leqembi
Drug slows cognitive decline by about 27% over 18 months, says Food and Drug Administration Source link
Read MoreDrug slows cognitive decline by about 27% over 18 months, says Food and Drug Administration Source link
Read MoreCoronavirus latest: AstraZeneca antibody drug offers 83% protection over 6 months Nikkei Asia AstraZeneca’s antibody cocktail helps prevent COVID-19 for at
Read More